Key Metrics
CiteScore 

4.5
Impact Factor 

< 5
SJR 

Q2Genetics

SNIP 

0.65
Recommended pre-submission checks
Powered by 

Topics Covered on Pharmacogenetics and Genomics
Pharmacogenetics and Genomics Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmacogenetics and Genomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Pharmacogenetics and Genomics
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease
- 13 Apr 2026
- Pharmacogenetics and Genomics
Characteristics of initial pharmacogenetic testing and subsequent physician referral behavior in youth mental health
- 7 Apr 2026
- Pharmacogenetics and Genomics
CFTR genotype-phenotype associations and clinical outcomes in pediatric cystic fibrosis.
- 7 Apr 2026
- Pharmacogenetics and genomics
NFIB rs28379954 does not affect CYP2D6-mediated metabolism of prototypical substrates, tamoxifen or solanidine.
- 24 Mar 2026
- Pharmacogenetics and genomics
Association of Genetic Variation in CES, UGT, ABC, and SLCO with Irinotecan Infusion Reactions and Severe Toxicity: Erratum
- 24 Mar 2026
- Pharmacogenetics and Genomics
The potential effect and pathway of valsartan: genome-wide and phenome-wide association study from UK Biobank data.
- 20 Mar 2026
- Pharmacogenetics and genomics
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease
- 13 Apr 2026
- Pharmacogenetics and Genomics
Characteristics of initial pharmacogenetic testing and subsequent physician referral behavior in youth mental health
- 7 Apr 2026
- Pharmacogenetics and Genomics
CFTR genotype-phenotype associations and clinical outcomes in pediatric cystic fibrosis.
- 7 Apr 2026
- Pharmacogenetics and genomics
NFIB rs28379954 does not affect CYP2D6-mediated metabolism of prototypical substrates, tamoxifen or solanidine.
- 24 Mar 2026
- Pharmacogenetics and genomics
Association of Genetic Variation in CES, UGT, ABC, and SLCO with Irinotecan Infusion Reactions and Severe Toxicity: Erratum
- 24 Mar 2026
- Pharmacogenetics and Genomics
The potential effect and pathway of valsartan: genome-wide and phenome-wide association study from UK Biobank data.
- 20 Mar 2026
- Pharmacogenetics and genomics